The Scripps Research Institute has been awarded a pair of grants totaling $6 million by the National Institutes of Health (NIH) to develop new therapeutic approaches to alcohol addiction and Fragile X syndrome, a form of inherited mental retardation that has often been linked to autism.

Claes Wahlestedt, M.D., Ph.D., a professor in the Departments of Neuroscience and Molecular Therapeutics at Scripps Florida, is the principal investigator for both projects.

Leave a Reply

Your email address will not be published. Required fields are marked *